Ads
related to: aromatase inhibitor breast cancer drug- Dosing Information
Read about dosing & admin
info. HCP resources available.
- Official Physician Site
Read about Verzenio®. Resources
available on the HCP site.
- Efficacy and Safety Info
Read efficacy and safety info.
Visit the official HCP site.
- Verzenio Resources
Find resources to share
with your patients.
- Savings Information
See how eligible patients
can save on Verzenio®
- Verzenio Vision™
Videos featuring leading experts
to inform you about Verzenio®.
- Dosing Information
Search results
Results From The WOW.Com Content Network
Aromatase inhibitors (AIs) are a class of drugs used in the treatment of breast cancer in postmenopausal women and in men, [1] [2] and gynecomastia in men. They may also be used off-label to reduce estrogen conversion when supplementing testosterone exogenously .
Exemestane, sold under the brand name Aromasin among others, is a medication used to treat breast cancer. It is a member of the class of antiestrogens known as aromatase inhibitors. Some breast cancers require estrogen to grow. Those cancers have estrogen receptors (ERs), and are called ER-positive. They may also be called estrogen-responsive ...
Steroidal aromatase inhibitors are a class of drugs that are mostly used for treating breast cancer in postmenopausal women. High levels of estrogen in breast tissue increases the risk of developing breast cancer and the enzyme aromatase is considered to be a good therapeutic target when treating breast cancer due to it being involved in the final step of estrogen biosynthetic pathway and also ...
NSAIs are mainly used to treat breast cancer in women. NSAIs binding is a reversible process where NSAIs binds to the aromatase enzyme through non-covalent interactions. When aromatase inhibitors (AIs) are used to treat breast cancer the main target is the aromatase enzyme which is responsible for the high estrogen level.
Letrozole, sold under the brand name Femara among others, is an aromatase inhibitor medication that is used in the treatment of breast cancer for post-menopausal women. [1]It was patented in 1986 and approved for medical use in 1996. [4]
Women post-menopause with ‘strong family history’ of breast cancer encouraged speak to GP about drug, expert says
Ads
related to: aromatase inhibitor breast cancer drug